Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.92 USD | +2.80% | +2.85% | -23.95% |
15/04 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
26/02 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.95% | 1.56B | |
-14.37% | 11.41B | |
+70.73% | 3.81B | |
-29.39% | 2.3B | |
-12.90% | 2.16B | |
+37.56% | 1.19B | |
-2.40% | 760M | |
-15.17% | 506M | |
-34.29% | 444M | |
+13.72% | 339M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Goldman Sachs Cuts Price Target on Veracyte to $32 From $35, Noting Decline in Peer Multiples; Buy Rating Maintained